- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on SARS-CoV-2 in India
Total 407 results
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
Eli Lilly and CompanyCompletedDiabetes Mellitus Type 2Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusEstonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes Mellitus | Hypercholesterolemia | Pre-diabetesUnited States, Colombia, India, Mexico
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, Chile, Czech Republic, India, Peru, Poland
-
PhenomixForest LaboratoriesCompletedType 2 Diabetes MellitusUnited States, Ukraine, Argentina, Malaysia, India, Romania, Thailand, Philippines, Peru
-
AstraZenecaCompletedType 2 DiabetesMexico, United States, Poland, Canada, Russian Federation, South Africa, France, Hungary, India, United Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
AstraZenecaTerminatedType 2 DiabetesItaly, United Kingdom, Germany, Philippines, Malaysia, Sweden, Finland, Canada, India, Australia, Singapore
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, France, India, Turkey, United Kingdom, Mexico, Brazil, Germany, Hungary, Puerto Rico, Saudi Arabia
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 DiabetesTaiwan, United States, Argentina, Canada, Mexico, Puerto Rico, Philippines, India, Peru
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Mexico, Japan, India, Puerto Rico, China
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1India
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes MellitusChina, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
-
Kowa Research EuropeCompletedDyslipidemia | Type II Diabetes MellitusIndia, Denmark, Germany, Netherlands, Poland, United Kingdom
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Thailand, United Kingdom, Malaysia, New Zealand, Taiwan, Turkey, Canada, Mexico, Israel, India, Argentina, Brazil, Russian Federation, Australia, Korea, Republic of, Italy, Philippines, Colombia, Poland, Chile, Finland and more
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, Spain, United States, India, Brazil
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Serbia, Hungary, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Germany, Sweden, South Africa, India, Poland, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Kowa Research EuropeCompletedDyslipidemia | Type II Diabetes MellitusIndia, Germany, Netherlands, Poland, Denmark, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1India
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Macedonia, The Former Yugoslav Republic of, Russian Federation, Turkey, Croatia, Australia, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Korea, Republic of, China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Germany, Mexico, Romania, Serbia, South Africa, Ukraine, Chile, Peru, Puerto Rico, Austria, Hungary, Slovakia, India, Czechia, Latvia, Argentina, United Kingdom
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more